Company profile: SmartCells
1.1 - Company Overview
Company description
- Provider of insulin and polymer-based products for diabetes, including SmartInsulin, a self-regulating injectable formulation, and polymer-based dosing technology for applications in fertility, thyroid, and growth hormone deficiencies, and treatments with poor compliance or therapeutic window.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SmartCells
Diabetomics
HQ: United States
Website
- Description: Provider of non-invasive medical diagnostics for personalized health and diabetes risk, offering point-of-care tests: Glucema saliva test for diabetes monitoring via glycosylated proteins; Lumella blood test for early preeclampsia via glycosylated fibronectin; Insudex for early type-1 diabetes and LADA via autoantibody titers; RAprime for rheumatoid arthritis from oral fluid or finger stick; CovAb oral-swab COVID-19 antibody test detecting IgA/IgM/IgG.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diabetomics company profile →
Sensulin
HQ: United States
Website
- Description: Provider of diabetes drug discovery focused on a once-a-day glucose-responsive insulin for type 1 and type 2 diabetes, designed to reduce hypoglycemia risk and long-term complications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sensulin company profile →
Medesis Pharma
HQ: France
Website
- Description: Provider of clinical-stage biopharmaceutical development leveraging AONYS, a buccal micro-emulsion platform enabling delivery of water-soluble actives across the blood-brain barrier, to develop orally administered candidates addressing unmet needs, including Nanolithium for Alzheimer's, NanoManganese for radiotherapy, NU01/NU02 for plutonium/cesium decorporation, and P42 for Huntington's.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medesis Pharma company profile →
Lifecare
HQ: Norway
Website
- Description: Provider of miniaturized, implantable glucose sensors and nano biosensing solutions. Offerings include Sencell, a real-time glucose sensor measuring osmotic pressure, lasting at least six months and transmitting data wirelessly to smart devices; NanoBioSensors for high-resolution diagnostics in live tissue; and Lifecare Veterinary for continuous animal glucose monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifecare company profile →
Bigfoot Biomedical
HQ: United States
Website
- Description: Provider of diabetes management solutions for insulin-requiring individuals, offering the Bigfoot Unity system that integrates with the FreeStyle Libre 2 sensor to provide insulin dose recommendations for multiple-daily-injection users, the Bigfoot Unity Mobile App for dosing and glucose data, and the Bigfoot Clinic Hub for clinician data review; adheres to security and privacy laws, including HIPAA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bigfoot Biomedical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SmartCells
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SmartCells
2.2 - Growth funds investing in similar companies to SmartCells
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SmartCells
4.2 - Public trading comparable groups for SmartCells
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →